Does enzyme replacement therapy improve symptoms of Fabry disease in patients undergoing dialysis?
Banikazemi
Maryam
M
Department of Human Genetics, Mount Sinai School of Medicine of New York University, New York, NY 10029-6574, USA.
Desnick
Robert J
RJ
D000795:Fabry Disease / Q000188:drug therapy* / Q000201:enzymology*; D006801:Humans; D007527:Isoenzymes / Q000627:therapeutic use*; D006435:Renal Dialysis; D000519:alpha-Galactosidase / Q000627:therapeutic use*
D007527:Isoenzymes; D000519:alpha-Galactosidase; C459420:agalsidase beta